Investigational immunosuppressants in early-stage clinical trials for the treatment of multiple sclerosis.
Gajofatto Alberto, Turatti Marco·Expert opinion on investigational drugs
INTRODUCTION: Multiple sclerosis (MS) is a chronic demyelinating disease of the central nervous system with an immune mediated pathogenesis. Several therapies that suppress or modulate diverse immune system functions have been used for decades with the aim of modifying the disease course. However, these treatments have…